Scaling up hepatitis C testing and linkage-to-care among people who use drugs: lessons learned from a pilot project implemented at a supervised consumption site
The Hep C Connect pilot explored the gaps evident in the HCV cascade-of-care as it pertains to people who use drugs. Findings suggest that, despite high levels of HCV knowledge, the employment of blood draw RNA testing deterred people from engaging in confirmatory testing. Improving the HCV cascade-of-care will require alternative strategies that are more acceptable to this population.
Authors
- Mark Hull (ORCID: https://orcid.org/0000-0002-9234-3531)
- Rolando Barrios (ORCID: https://orcid.org/0000-0003-3642-5986)
- David S. Hall (ORCID: https://orcid.org/0000-0001-9632-0399)
- Sofia Bartlett (ORCID: https://orcid.org/0000-0003-0699-2250)
- Ailish Hannigan (ORCID: https://orcid.org/0000-0003-0554-2741)
- Julio Montaner (ORCID: https://orcid.org/0000-0002-6201-9829)
- Kate Salters (ORCID: https://orcid.org/0000-0002-6280-2290)
- Deb Schmitz
- Nandini Krishnan
- Marianne Harris
- Kirti Singh
- Shannon Bytelaar
Institutions
- University of British Columbia (CA)
- BC Centre for Disease Control (CA)
- AIDS Vancouver (CA)
Publication Details
- Journal
- BMC Health Services Research
- Published
- 2025-02-13
- DOI
- https://doi.org/10.1186/s12913-025-12374-9
- Citations
- 2
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 2.64
Funders
- Gilead Sciences